OR WAIT null SECS
© 2022 MJH Life Sciences and Optometry Times. All rights reserved.
© 2022 MJH Life Sciences™ and Optometry Times. All rights reserved.
September 23, 2022
The treatment of vision problems can help improve the quality of life for many people in the city.
September 22, 2022
Experts answer clinicians’ common questions on treating patients.
September 20, 2022
AREDS2 formula doesn’t contain beta carotene, reducing the risk of lung cancer.
September 19, 2022
Evolving phakic IOL offers high-definition vision.
September 18, 2022
As technology improves, less-invasive treatments save patients time and money.
September 17, 2022
When oral acne treatments lead to ocular surface disease, the solution lies in office-based therapies.
September 16, 2022
Melissa Barnett, OD, from the University of California, Davis Eye Center, Sacramento and Davis, CA, described new strategies, technologies, and drug classes to treat chronic conditions that include myopia, Demodex infestation, meibomian gland dysfunction, glaucoma drug delivery, advancements in corneal and cataract surgeries, and presbyopia
Optometrists are seeing recent advances in topical therapies that entered the market following decades of reliance of traditional single-agent drops. An implantable device that facilitates the slow release of drug is changing the landscape in glaucoma therapy.
September 15, 2022
Justin Schweitzer, OD, FAAO, reports that glaucoma therapy is quickly moving to more innovative and targeted ways to treat glaucoma and lower the patient treatment burden.
Brandon Barber, chief marketing officer at Heru, shares about the company's new dark adaptation modality, which they announced during the 2022 Vision Expo West, as well as other advancements in the pipeline.
Unaddressed visual problems negatively impacts safety earnings of workers in underdeveloped countries
What to know about new topical presbyopia-correcting drops
Supplements slow AMD progression, study data confirm
Welcome to the EVO-lution